Iteris (ITI) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ITI Hot Sheet
Price: $7.19 --0%
Financial Fact:
Total operating expenses: 9.64M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 9.64M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Iteris (NASDAQ: ITI) reported Q3 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $19 million versus the consensus estimate of $17.84 million.
For earnings history and earnings-related data on Iteris (ITI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
